According to Immunic's latest financial reports the company's current EPS (TTM) is -$5.47. In 2022 the company made an earnings per share (EPS) of -$6.01 an increase over its 2021 EPS that were of -$6.08.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$5.12 | -14.85% |
2022 | -$6.01 | -1.05% |
2021 | -$6.08 | 33.68% |
2020 | -$4.55 | -64.33% |
2019 | -$12.74 | -79.62% |
2018 | -$62.52 | -26.32% |
2017 | -$84.84 | 2.31% |
2016 | -$82.93 | -38.1% |
2015 | -$133.96 | -23.48% |
2014 | -$175.07 | -88.9% |
2013 | -$1,578 |